Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Non Operating Income: 2016-2024

Historic Non Operating Income for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -$1.5 million.

  • Organogenesis Holdings' Non Operating Income rose 203.34% to $433,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 204.17%. This contributed to the annual value of -$1.5 million for FY2024, which is 28.55% up from last year.
  • Per Organogenesis Holdings' latest filing, its Non Operating Income stood at -$1.5 million for FY2024, which was up 28.55% from -$2.1 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Non Operating Income peaked at -$1.5 million during FY2024, and registered a low of -$9.1 million during FY2021.
  • For the 3-year period, Organogenesis Holdings' Non Operating Income averaged around -$1.9 million, with its median value being -$2.0 million (2022).
  • In the last 5 years, Organogenesis Holdings' Non Operating Income skyrocketed by 77.86% in 2022 and then dropped by 5.49% in 2023.
  • Organogenesis Holdings' Non Operating Income (Yearly) stood at -$8.9 million in 2020, then decreased by 2.19% to -$9.1 million in 2021, then spiked by 77.86% to -$2.0 million in 2022, then declined by 5.49% to -$2.1 million in 2023, then increased by 28.55% to -$1.5 million in 2024.